Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, +17

Journal for ImmunoTherapy of Cancer

Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer

Ulrich Kaiser, Jürgen Hofmann, M. Schilli, +8

International Journal of Cancer

Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial

Christopher Parker, Robert E. Coleman, Oliver Sartor, +26

European Urology

A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer

Paweł Wiechno, Bradley G. Somer, Begoña Mellado, +15

European Urology

UrologyGenitourinary CancerMedicinePharmacologyRandomised Phase 2 +6

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma <i>in vitro</i> and <i>in vivo</i>

Jon Jones, Eva Juengel, Ausra Mickuckyte, +4

Journal of Cellular and Molecular Medicine

Chemoprevention StrategyRenal PathologyTumor BiologyGenitourinary CancerVpa-ifn-alpha Combination +15

CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells

Jon Jones, Dana Marian, Eva Weich, +5

Experimental Cell Research

MedicineCell AdhesionCell TraffickingImmunologyCell-matrix Interaction +8

Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells

Steffen Wedel, Lukasz Hudak, Jens‐Michael Seibel, +6

Clinical & Experimental Metastasis

UrologyMtor InhibitionCell AdhesionMedicineProstate Cancer Cells +8

Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001

Steffen Wedel, Lukasz Hudak, Jens‐Michael Seibel, +5

Life Sciences

UrologyOncologyMedicinePharmacotherapyAnti-cancer Agent +7

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma

Steffen Wedel, Anna Sparatore, Piero Del Soldato, +6

Journal of Cellular and Molecular Medicine

Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis

Steffen Wedel, Lukasz Hudak, Jens‐Michael Seibel, +6

BMC Cancer